BCR and neoplasm: To determine whether tumor‐infiltrating B cells of the high HER2‐AAb group responded to specific TAAs including HER2, we examined the mRNA sequence of the CDR3 region of the IgHV and IgHJ genes by the unbiased amplification of BCR genes followed by next‐generation sequencing.17, 18